{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:17:26Z","timestamp":1785770246036,"version":"3.56.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare monogenic autoimmune disease with variable clinical manifestations, ranging from early-onset severe autoimmunity, including enteropathy, eczema, and type 1 diabetes, to late-onset or atypical symptoms. Despite the clinical heterogeneity, the unifying feature of IPEX is mutation of the <jats:italic>FOXP3<\/jats:italic> gene, which encodes a transcription factor essential for maintenance of thymus-derived regulatory T cells (Tregs). In IPEX patients, Tregs can be present, although unstable and impaired in function, unable to inhibit proliferation and cytokine production of effector T (Teff) cells. Mutated FOXP3 can also disrupt other compartments: FOXP3-deficient Teff cells proliferate more than the wild-type counterpart, display altered T-cell-receptor signaling response, a reduced T-na\u00efve compartment and a skew toward a Th2 profile. Due to <jats:italic>FOXP3<\/jats:italic> mutations, the frequency of autoreactive B cells is increased and the IgA and IgE production is altered, together with early emergence of tissue-specific autoantibodies. Recently, the awareness of the wide clinical spectrum of IPEX improved the diagnostic tools. In cases presenting with enteropathy, histological evaluation is helpful, although there are no pathognomonic signs of disease. On the other hand, the study of FOXP3 expression and <jats:italic>in vitro<\/jats:italic> Treg function, as well as the detection of specific circulating autoantibodies, is recommended to narrow the differential diagnosis. Nowadays, Sanger sequencing should be limited to cases presenting with the classical triad of symptoms; otherwise, next-generation sequencing is recommended, given the cost-effectiveness and the advantage of excluding IPEX-like syndromes. The latter approach could be time spearing in children with severe phenotypes and candidate to advanced therapies.<\/jats:p>","DOI":"10.3389\/fped.2021.612760","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T04:52:23Z","timestamp":1613969543000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Federica","family":"Barzaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"Journal Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Investig."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, x-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.jaut.2020.102461","article-title":"The progress and prospect of regulatory T cells in autoimmune diseases","volume":"111","author":"Zhang","year":"2020","journal-title":"J Autoimmun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/08830185.2013.863303","article-title":"Forkhead box P3: the peacekeeper of the immune system","volume":"33","author":"Passerini","year":"2014","journal-title":"Int Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.clim.2011.06.006","article-title":"Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"141","author":"Otsubo","year":"2011","journal-title":"Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.immuni.2017.07.008","article-title":"Analyses of a mutant Foxp3 allele reveal BATF as a critical transcription factor in the differentiation and accumulation of tissue regulatory T cells","volume":"47","author":"Hayatsu","year":"2017","journal-title":"Immunity."},{"key":"B14","doi-asserted-by":"publisher","first-page":"eaai9297","DOI":"10.1126\/sciimmunol.aai9297","article-title":"Suppression by human FOXP3(+) regulatory T cells requires FOXP3-TIP60 interactions","volume":"2","author":"Bin Dhuban","year":"2017","journal-title":"Sci Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2010.09.001","article-title":"Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells","volume":"126","author":"McMurchy","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jaci.2011.09.010","article-title":"Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability","volume":"128","author":"Passerini","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin","year":"2007","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.immuni.2007.09.010","article-title":"Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature","volume":"27","author":"Hill","year":"2007","journal-title":"Immunity."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","article-title":"Functional reprogramming of regulatory T cells in the absence of Foxp3","volume":"20","author":"Charbonnier","year":"2019","journal-title":"Nat Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.4049\/jimmunol.1900662","article-title":"Regulatory T cell development in the thymus","volume":"203","author":"Owen","year":"2019","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ni1445","article-title":"Regulatory T cell development in the absence of functional Foxp3","volume":"8","author":"Lin","year":"2007","journal-title":"Nat Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/JCI25112","article-title":"Defective regulatory and effector T cell functions in patients with FOXP3 mutations","volume":"116","author":"Bacchetta","year":"2006","journal-title":"J Clin Investig."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1056\/NEJMc0907093","article-title":"FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome","volume":"361","author":"d'Hennezel","year":"2009","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2011.12.009","article-title":"Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome","volume":"38","author":"Barzaghi","year":"2012","journal-title":"J Autoimmun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/intimm\/dxl060","article-title":"Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis","volume":"18","author":"Sugimoto","year":"2006","journal-title":"Int Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","article-title":"Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity","volume":"122","author":"Gambineri","year":"2008","journal-title":"J Allergy Clin Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1182\/blood-2009-04-214593","article-title":"Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations","volume":"114","author":"Di Nunzio","year":"2009","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1182\/blood-2009-02-206359","article-title":"Selective engraftment of donor CD4+25 high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation","volume":"113","author":"Seidel","year":"2009","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clim.2018.03.008","article-title":"IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective TReg cell engraftment","volume":"191","author":"Magg","year":"2018","journal-title":"Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.jaci.2018.03.015","article-title":"Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis","volume":"142","author":"Santoni de Sio","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"215ra174","DOI":"10.1126\/scitranslmed.3007320","article-title":"CD4(+) T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer","volume":"5","author":"Passerini","year":"2013","journal-title":"Sci Transl Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Mol Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/mt.2009.48","article-title":"Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform","volume":"17","author":"Amendola","year":"2009","journal-title":"Mol Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1172\/JCI24685","article-title":"The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs","volume":"115","author":"Allan","year":"2005","journal-title":"J Clin Investig."},{"key":"B42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.molmed.2012.06.001","article-title":"Functional stability of Foxp3+ regulatory T cells","volume":"18","author":"da Silva Martins","year":"2012","journal-title":"Trends Mol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2018.12.016","article-title":"A Mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells","volume":"50","author":"Van Gool","year":"2019","journal-title":"Immunity."},{"key":"B46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3466","article-title":"Immunometabolism of regulatory T cells","volume":"17","author":"Newton","year":"2016","journal-title":"Nat Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2012-05-431023","article-title":"A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells","volume":"121","author":"McMurchy","year":"2013","journal-title":"Blood."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","article-title":"Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells","volume":"121","author":"Kinnunen","year":"2013","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaci.2019.02.031","article-title":"The autoimmune targets in IPEX are dominated by gut epithelial proteins","volume":"144","author":"Eriksson","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2019.03.011","article-title":"Identification of autoantibodies using human proteome microarrays in patients with IPEX syndrome","volume":"203","author":"Hoshino","year":"2019","journal-title":"Clin Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2012.00211","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity","volume":"3","author":"Barzaghi","year":"2012","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izz259","article-title":"Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies","volume":"26","author":"Ouahed","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gendis.2019.10.003","article-title":"Genetics on early onset inflammatory bowel disease: an update","volume":"7","author":"Nameirakpam","year":"2020","journal-title":"Genes Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome","volume":"8","author":"Jamee","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41424-018-0064-x","article-title":"Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a french multicenter retrospective study","volume":"9","author":"Duclaux-Loras","year":"2018","journal-title":"Clin Transl Gastroenterol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J Clin Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fped.2017.00267","article-title":"Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome with intractable diarrhea: a case report","volume":"5","author":"Ge","year":"2017","journal-title":"Front Pediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13052-014-0068-4","article-title":"Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea","volume":"40","author":"Zama","year":"2014","journal-title":"Ital J Pediatr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archderm.140.4.466","article-title":"Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"140","author":"Nieves","year":"2004","journal-title":"Arch Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J Med Genet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cgh.2005.12.014","article-title":"Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome","volume":"4","author":"De Benedetti","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2350\/06-07-0130.1","article-title":"A potential screening tool for IPEX syndrome","volume":"10","author":"Heltzer","year":"2007","journal-title":"Pediatr Dev Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MPG.0b013e3181a159de","article-title":"Severe gastritis in an insulin-dependent child with an IPEX syndrome","volume":"49","author":"Scaillon","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1210\/jc.2003-031080","article-title":"Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome","volume":"88","author":"Owen","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/(SICI)1096-8628(20000228)90:5<390::AID-AJMG9>3.0.CO","article-title":"Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome","volume":"90","author":"Ferguson","year":"2000","journal-title":"Am J Med Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jmg.38.12.874","article-title":"Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX)","volume":"38","author":"Kobayashi","year":"2001","journal-title":"J Med Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2005.04.017","article-title":"Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)","volume":"147","author":"Bindl","year":"2005","journal-title":"J Pediatr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2008.161","article-title":"Digestive histopathological presentation of IPEX syndrome","volume":"22","author":"Patey-Mariaud de Serre","year":"2009","journal-title":"Mod Pathol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.gastro.2010.06.006","article-title":"Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy","volume":"139","author":"Moes","year":"2010","journal-title":"Gastroenterology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00467-015-3102-x","article-title":"Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder","volume":"30","author":"Sheikine","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","article-title":"Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation","volume":"34","author":"Baris","year":"2014","journal-title":"J Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jaci.2010.05.021","article-title":"Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"126","author":"Burroughs","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1365-2249.1998.00523.x","article-title":"A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy","volume":"111","author":"Kobayashi","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2006-05-025072","article-title":"Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning","volume":"109","author":"Rao","year":"2007","journal-title":"Blood."},{"key":"B78","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneousmanifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"160","author":"Halabi-Tawil","year":"2009","journal-title":"Br J Dermatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/j.gastro.2007.02.044","article-title":"Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene","volume":"132","author":"Torgerson","year":"2007","journal-title":"Gastroenterology."},{"key":"B80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.jaad.2006.01.008","article-title":"Norwegian scabies mimicking onychomycosis and scalp dermatitis in a child with IPEX syndrome","volume":"56","author":"McLucas","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0016-5085(99)70340-9","article-title":"Identification of an autoimmune enteropathy-related 75-kilodalton antigen","volume":"117","author":"Kobayashi","year":"1999","journal-title":"Gastroenterology."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e78664","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS ONE."},{"key":"B86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clim.2011.05.010","article-title":"Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3","volume":"141","author":"Kobayashi","year":"2011","journal-title":"Clin Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fimmu.2018.00544","article-title":"Neutralizing anti-cytokine autoantibodies against interferon-alpha in immunodysregulation polyendocrinopathy enteropathy X-linked","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Front Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaut.2010.06.017","article-title":"The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies","volume":"35","author":"Tsuda","year":"2010","journal-title":"J Autoimmun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"eaan3508","DOI":"10.1126\/scitranslmed.aan3508","article-title":"Epigenetic immune cell counting in human blood samples for immunodiagnostics","volume":"10","author":"Baron","year":"2018","journal-title":"Sci Transl Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.alit.2017.06.003","article-title":"Flow cytometry-based diagnosis of primary immunodeficiency diseases","volume":"67","author":"Kanegane","year":"2018","journal-title":"Allergol Int."},{"key":"B91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clim.2014.12.007","article-title":"Fetal-onset IPEX: report of two families and review of literature","volume":"156","author":"Xavier-da-Silva","year":"2015","journal-title":"Clin Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2018.12.003","article-title":"Lentiviral gene therapy in HSCs restores lineage-specific Foxp3 expression and suppresses autoimmunity in a mouse model of IPEX syndrome","volume":"24","author":"Masiuk","year":"2019","journal-title":"Cell Stem Cell."},{"key":"B93","doi-asserted-by":"publisher","first-page":"eaaz0571","DOI":"10.1126\/sciadv.aaz0571","article-title":"CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells","volume":"6","author":"Goodwin","year":"2020","journal-title":"Sci Adv."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.612760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T04:52:27Z","timestamp":1613969547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.612760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":93,"alternative-id":["10.3389\/fped.2021.612760"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.612760","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"article-number":"612760"}}